Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: valueminded who wrote (4951)	7/17/1998 12:36:00 PM
From: mc	Read Replies (2) \| Respond to of 7041

To all, what do you think the possibilities are of ZONA reporting good sales to Schering Plough in the second quarter regardless of actual end sales figures? They do have to at least fill the supply pipeline right? We could see some surprising numbers. Of course, we won't know if they are sustainable or not, but, they might be larger than expected. Gary

To: valueminded who wrote (4951)	7/17/1998 4:22:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

You may want to try IBM's patent search engine (I forget the web address right offhand) to read about Zonagen's two bogus patents. You can also go to any medical school library or get a PDR to research Phentolamine Mesylate (Regitine). If you do a web search for Phentolamine, you can pick up lots of bibliographic references as well.

To: valueminded who wrote (4951)	7/17/1998 6:39:00 PM
From: Brander	Respond to of 7041

Here is a direct link to the patent for rapidly dissolving phentolamine, approved March 24, 1998: patents.ibm.com